We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA: IRB Corrects Consent Issues but Other Problems Remain
FDA: IRB Corrects Consent Issues but Other Problems Remain
January 20, 2010
Although an IRB has rectified FDA concerns regarding a lack of required information in consent forms, the board needs to specify how it plans to ensure
staff assesses studies and risks, an FDA warning letter says.